1. Home
  2. CYD vs IMNM Comparison

CYD vs IMNM Comparison

Compare CYD & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

HOLD

Current Price

$34.75

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$19.76

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYD
IMNM
Founded
1951
2006
Country
Singapore
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.8B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
CYD
IMNM
Price
$34.75
$19.76
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$26.89
AVG Volume (30 Days)
164.2K
1.3M
Earning Date
08-08-2025
11-06-2025
Dividend Yield
1.53%
N/A
EPS Growth
40.10
N/A
EPS
1.66
N/A
Revenue
$3,159,401,156.00
$9,679,000.00
Revenue This Year
$41.12
N/A
Revenue Next Year
$6.93
N/A
P/E Ratio
$20.90
N/A
Revenue Growth
17.99
N/A
52 Week Low
$8.61
$5.15
52 Week High
$42.60
$20.46

Technical Indicators

Market Signals
Indicator
CYD
IMNM
Relative Strength Index (RSI) 44.55 64.30
Support Level $34.75 $16.81
Resistance Level $36.30 $18.96
Average True Range (ATR) 1.56 1.22
MACD -0.03 0.07
Stochastic Oscillator 47.70 85.21

Price Performance

Historical Comparison
CYD
IMNM

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: